Diffusion Pharmaceuticals Inc. (DFFN) financial statements (2020 and earlier)

Company profile

Business Address 2020 AVON COURT
CHARLOTTESVILLE, VA 22902
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1489212220
Cash and cash equivalents1489212220
Other undisclosed current assets0110023
Total current assets:15910212243
Noncurrent Assets
Operating lease, right-of-use asset0
Property, plant and equipment0000000
Long-term investments and receivables    0  
Long-term investments    0  
Intangible assets, net (including goodwill)99161671915
Goodwill  771128
Intangible assets, net (excluding goodwill)9999668
Other noncurrent assets0000   
Total noncurrent assets:99161681915
TOTAL ASSETS:24182617204318
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2123132
Accounts payable1012002
Accrued liabilities012112 
Employee-related liabilities     1 
Other undisclosed accounts payable and accrued liabilities      0
Debt0 12  2
Due to related parties      0
Other undisclosed current liabilities     (1)5
Total current liabilities:2134129
Noncurrent Liabilities
Long-term debt and lease obligation0  1   
Long-term debt, excluding current maturities   1   
Operating lease, liability0
Liabilities, other than long-term debt2223   
Deferred tax liabilities, net223   
Deferred income tax liabilities2
Other liabilities  00   
Other undisclosed noncurrent liabilities    223
Total noncurrent liabilities:2224223
Total liabilities:43583512
Stockholders' equity
Stockholders' equity attributable to parent201621916386
Common stock0000000
Additional paid in capital11296836911611367
Accumulated deficit(92)(80)(62)(60)(99)(75)(61)
Stockholders' equity attributable to noncontrolling interest      0
Total stockholders' equity:201621916386
TOTAL LIABILITIES AND EQUITY:24182617204318

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Gross profit:      0
Operating expenses(12)(19)(11)(18)(24)(15)(13)
Operating loss:(12)(19)(11)(18)(24)(15)(13)
Nonoperating income (expense)  (3) 0(3)(10)
Other nonoperating income (expense)  (3) 00(0)
Interest and debt expense (0)(0)(0) (0)0
Loss from continuing operations before equity method investments, income taxes:(12)(19)(14)(18)(24)(17)(23)
Other undisclosed income from continuing operations before income taxes0012  0 
Loss from continuing operations before income taxes:(11)(19)(2)(18)(24)(17)(23)
Income tax expense (benefit)(0)010 3 
Loss before gain (loss) on sale of properties:(12)(18)(1)(18)(24)(14)(23)
Other undisclosed net income      21
Net loss:(12)(18)(1)(18)(24)(14)(2)
Net loss attributable to noncontrolling interest      (0)
Net loss attributable to parent:(12)(18)(1)(18)(24)(14)(2)
Preferred stock dividends and other adjustments (8)(1)    
Other undisclosed net loss available to common stockholders, basic      (0)
Net loss available to common stockholders, basic:(12)(27)(3)(18)(24)(14)(3)
Other undisclosed net loss available to common stockholders, diluted  (22)    
Net loss available to common stockholders, diluted:(12)(27)(25)(18)(24)(14)(3)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(12)(18)(1)(18)(24)(14)(2)
Comprehensive loss:(12)(18)(1)(18)(24)(14)(2)
Comprehensive income, net of tax, attributable to noncontrolling interest      0
Comprehensive loss, net of tax, attributable to parent:(12)(18)(1)(18)(24)(14)(2)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: